Synexus acquires three clinical research centres in Poland
This article was originally published in Scrip
Executive Summary
Synexus, a Manchester-based company, has acquired a Polish company called CLCC (Centrum Leczenia Chorob Cywilizacyjnych), which owns clinical trials sites in Warsaw, Gdynia and Katowice. Synexus specialises in patient recruitment and running later stage clinical trials for pharmaceutical, biotech and CROs.